Literature DB >> 2830394

The effects of azole and polyene antifungals on the plasma membrane enzymes of Candida albicans.

R Surarit1, M G Shepherd.   

Abstract

The two clinically important classes of antimycotic drugs, the polyenes and azoles, act on the plasma membrane of the cell. The primary modes of action are believed to be through interaction with sterols (polyenes) and alteration in sterol composition of the membrane (azoles). In this report we show that, at growth inhibitory concentrations, the polyenes (nystatin and amphotericin) and azoles (miconazole and ketoconazole) also inhibit plasma membrane enzymes. There was extensive (greater than 75%) inhibition of the Candida albicans plasma membrane enzymes ATPase, glucan synthase, adenyl cyclase and 5'-nucleotidase, when assayed in situ. The antifungals papulacandin and echinocandin, which inhibit glucan synthesis, also inhibited plasma membrane enzymes in situ; glucan synthase (greater than 90%), 5'-nucleotidase (greater than 80%) and ATPase (70-80%). Purified plasma membrane was prepared from yeast cells of C. albicans by two different techniques: concanavalin A stabilization and coating of spheroplasts with silica microbeads. In the purified plasma membrane vesicles prepared from concanavalin A the adenyl cyclase and phosphodiesterase were extensively (greater than 90%) inhibited by the three different classes of antifungal drugs; variable inhibition was observed with ATPase (70-100%). The 3',5'-cyclic phosphodiesterase of the plasma membrane purified by the microbeads method was almost completely inhibited by all of the antifungals tested and there was partial inhibition of ATPase (20-85%) and adenyl cyclase (30-90%).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830394     DOI: 10.1080/02681218780000491

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  18 in total

1.  Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.

Authors:  Xiaolong Tang; Ronghong Jiao; Chunmei Xie; Lifa Xu; Zhen Huo; Jingjing Dai; Yunyun Qian; Weiwen Xu; Wei Hou; Jiang Wang; Yong Liang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 3.  Candidosis of the oral cavity. Recognition and management.

Authors:  K D Hay
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  Enhanced action of amphotericin B on Leishmania mexicana resulting from heat transformation.

Authors:  H Ramos; J Milhaud; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 6.  Compounds active against cell walls of medically important fungi.

Authors:  R F Hector
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

Review 7.  Use of amphotericin B with azole antifungal drugs: what are we doing?

Authors:  A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Na+, K+ and Cl- selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics.

Authors:  S C Hartsel; S K Benz; W Ayenew; J Bolard
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

Review 9.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

10.  Anti-Candida and mode of action of two newly synthesized polymers: a modified poly (methylmethacrylate-co-vinylbenzoylchloride) and a modified linear poly (chloroethylvinylether-co-vinylbenzoylchloride) with special reference to Candida albicans and Candida tropicalis.

Authors:  Yehia A G Mahmoud; Magda M Aly
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.